18 Recruiting Advanced Lung Non-Small Cell Carcinoma Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Advanced Lung Non-Small Cell Carcinoma
Related Conditions
Top Recruiting Advanced Lung Non-Small Cell Carcinoma Studies
Telaglenastat Hydrochloride and Osimertinib in Treating Patients With EGFR-Mutated Stage IV Non-small Cell Lung Cancer
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
View Study & Checklist ➔Genetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small Cell Lung Cancer Previously Treated With PD-1 and/or PD-L1 Immune Checkpoint Inhibitors
📍 Chao Family Comprehensive Cancer Center University of California, Irvine — Orange, California
View Study & Checklist ➔Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)
📍 Veterans Administration Medical Center - Birmingham — Birmingham, Alabama
View Study & Checklist ➔Minnelide and Osimertinib for the Treatment of Advanced EGFR Mutated Non-Small Cell Lung Cancer
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔CIMAvax-EGF With KRAS G12C Inhibitor for the Treatment of Advanced, KRAS G12C Mutated Non Small Cell Lung Cancer
📍 Roswell Park Cancer Institute — Buffalo, New York
View Study & Checklist ➔Carfilzomib in Combination With Sotorasib for the Treatment of Patients With KRAS G12C Mutated Advanced or Metastatic Non-small Cell Lung Cancer
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
View Study & Checklist ➔Diclofenac for the Treatment of Patients With Metastatic Non-small Cell Lung Cancer on Single Agent Immunotherapy
📍 Emory University Hospital Midtown — Atlanta, Georgia
View Study & Checklist ➔GT103 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic STK11 Mutant Non-Small Cell Lung Cancer
📍 Roswell Park Cancer Institute — Buffalo, New York
View Study & Checklist ➔MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer
📍 Emory University Hospital/Winship Cancer Institute — Atlanta, Georgia
View Study & Checklist ➔Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
📍 Highlands Oncology Group - Fayetteville — Fayetteville, Arkansas
View Study & Checklist ➔SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
View Study & Checklist ➔